Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether erlotinib plus pemetrexed, cisplatin are
effective and safe in treating lung adenocarcinoma with brain metastases.